CytRx Corporation (CYTR) Stock: Falling Hard On Offering

CytRx Corporation (NASDAQ: CYTR) is having an overwhelmingly rough day in the market today after the comapny announced that it will be moving forward with a registered direct offering. Of course, these offerings lead to dilution, which is causing fear among investors and sending the stock spiraling downward. Today, we’ll talk about: The offering; what … Read more

CytRx Corporation (CYTR) Stock: Heads Up On Management Changes

CytRx Corporation (NASDAQ: CYTR) is having a relatively strong start in the market this morning after announcing management changes. After bringing a new President and CEO on board, CYTR excited investors and the stock is headed for the top. Today, we’ll talk about: The announcement; what we’re seeing from CYTR; and what we’ll be watching … Read more

CytRx Corporation (CYTR) Stock: Heading Up On Breakthrough Data

CytRx Corporation (NASDAQ: CYTR) is having a relatively strong start to the trading session this morning, and for good reason. The company presented breakthrough data, suggesting that four candidates may be qualified for Investigational New Drug status, enabling clinical studies on the treatments. Of course, this proved to be exciting news for investors who are … Read more

CytRx Corporation (CYTR) Stock: Flying On Coming Presentation Of Data

CytRx Corporation (NASDAQ: CYTR) is having an overwhelmingly strong start to the trading session this morning after announcing that it will be providing various presentations relatively soon. Of course, with excitement brewing surrounding the presentations, investors are sending the stock screaming for the top. Today, we’ll talk about: The presentations that are around the corner; … Read more

CytRx Corporation (CYTR) Stock: Continues Upward On License Agreement News

CytRx Corporation (NASDAQ: CYTR) is having an great start to the trading session in the pre-market hours, following up on incredible gains that were seen on the stock on Friday. The reason for the movement is relatively simple. Investors remain excited about the license agreement that was announced late last week. Of course, our partners … Read more

CytRx Corporation (CYTR) Stock: Gaining On Dismissal Of Class Action Suit

CytRx Corporation (NASDAQ: CYTR) is having an overwhelmingly strong morning in the pre-market hours this morning, and for good reason. A lawsuit the company has been facing has been dismissed by the judge. As a result, investors are excited and they are pushing the value of the stock upward. Of course, our partners at Trade … Read more